Cadrenal Therapeutics, Inc. · NASDAQ:CVKD

Pham Quang X sold 8,285 Cadrenal Therapeutics, Inc. shares (Form 4)

Traded Jun 3 to Jun 5, 2026 · Filed Jun 5, 2026

From Jun 3 to Jun 5, 2026, Pham Quang X (Director, CEO and Chairman, 10% owner) sold 8,285 Cadrenal Therapeutics, Inc. shares at an average US$4.37 for US$36,209 under a trading plan, leaving 173,224 shares. Filed Jun 5, 2026 (Form 4).

Sold
8,285 shares
Price
US$4.37 average (US$4.26 to US$4.42)
Value
US$36,209
Holding after
173,224 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CEO and Chairman, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 3, 2026Common StockSale2,323US$4.26179,186Direct
Jun 4, 2026Common StockSale3,898US$4.41175,288Direct
Jun 5, 2026Common StockSale2,064US$4.42173,224Direct

Source

View original at SEC

Related